Baptist Colleagues Raise $1 Million for Baptist Trinity Hospice House and Kemmons Wilson Family Center for Good Grief

...se is. In addition to the Kemmons Wilson Family Foundation, other lead gifts have been made by Marcia and George Bryan, The Assisi Foundation and plough Foundation. Significant gifts have also been pledged by Ann and Steve Reynolds, Huddy and Bayard Boyle, Crawford Investment Counsel, Andrea and Doug E...

Cell Therapeutics, Inc. (CTI) President Craig Philips to Present at Invest Northwest

...r at Berlex Oncology. He was responsible for the U.S. oncology operations with sales of over $160 million. Prior to Berlex, Philips was with Schering plough in U.S., global, and international roles. He began his career with Bristol Myers, where he worked in a variety of therapy areas including oncology, c...

ORNL, UT project could save vision of millions

...he expert knowledge of an ophthalmologist in a patient archive." Leading the medical portion of the project is Edward Chaum, an ophthalmologist and plough Foundation professor of retinal diseases at the University of Tennessee Health Science Center ( http://www.eye.utmem.edu ) Hamilton Eye Institute in M...

Craig W. Philips Takes Helm at CTI

...lex Oncology since 2004. He was responsible for the U.S. oncology operations with sales of over $160 million. Before Berlex, Philips was with Schering plough in U.S., and international roles. He began his career with Bristol Myers, where he worked in a variety of therapy areas including oncology, cardiology...

Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture

...er for the proposed fixed-dose combination of loratadine and montelukast. As a result of the termination of the respiratory joint venture, Schering- plough expects to receive payments totaling $105 million from Merck as specified in the joint venture agreements which Schering-Plough will recognize over th...

Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab

...elating to the timing of filing applications for golimumab. Forward-looking statements relate to expectations or forecasts of future events. Schering- plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering- Pl...

Europe to tackle brain disorder research by linking industry, academia

...try more concerned with improving existing therapies and determining correct combinations of drugs and dosage levels. Meanwhile academia has tended to plough too many small furrows, without tackling the big picture. The EuroBioForum conference will provide the platform for researchers to unite behind a ...

Marketing and Meeting Details (M2D) Officially Launches an Innovative Life Sciences Marketing and Communications Company

...nferences with Real-Time Polling M2D's website http://www.m2details.com . Celebrex, Cipro and Clarinex are products of Pfizer, Bayer and Schering- plough respectively. Contact: M2D Media Relations Phone: 781-210-4710 Fax: 781-210-4711 Email: MediaRelations@m2details...

Direct Relief International Aims California Fire Response at Health Concerns

... Relief also is drawing upon 25,000 inhalers in its inventory to respond to specific requests by medical staff at regional health facilities. Schering plough donated the inhalers to Direct Relief. Partner clinics are reporting an increased need for products to treat patients experiencing breathing complica...

Schering-Plough Reports Financial Results for Third Quarter of 2007

...rial to the company's financial results. Schering- plough still needs to secure certain other regulatory app...90 million in the third quarter of 2006. Schering- plough noted that it incurs substantial costs such as sel...treatment for inflammatory diseases that Schering- plough markets in countries outside the United States (ex...

Plough in Medical Technology

New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients

...tp://www.RocheExchange.com . All trademarks used or mentioned in this release are protected by law. PegIntronTM is a trademark product of Schering plough Corporation. (1) Rumi M, Aghemo A, Prati G, et al. Randomized study comparing peginterferon-alfa-2a plus ribavirin and peginterferon-alfa-2b plus ri...

Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C

...d low relapse rate of PEGINTRON in combination with weight-based REBETOL." WIN-R was an investigator-initiated clinical study supported by Schering- plough Corporation as part of a post-marketing commitment to the FDA. About Hepatitis C Hepatitis C is a serious and potentially life-threatening disease...

SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients

...evation MI undergoing PCI ," said Rick Veltri, M.D., Group Vice President of Global Clinical Research, Cardiovascular and Metabolic Disease, Schering- plough Research Institute. "With our global Phase III clinical development program underway, we are continuing to evaluate the potential for TRA as a novel a...

Plough in Biological News

ASBMB taps 8 scientists for top awards

...tor and Professor at the University of Massachusetts Medical School, will be presented with the Schering-Plough Research Institute Award. The Schering plough Award was established to recognize young investigators for outstanding research at an early stage of their careers. A pioneer in the study of RNA sile...

Plough in Biological Technology

Novavax and Vivalis Sign a Research License Agreement to Use the EB66(R) Cell Line for the Production of Virus Like Particle Based Vaccines

..., notably, Sanofi Pasteur, GSK, Bavarian Nordic, CSL, Kaketsuken, Schering plough (Nobilon), Geovax, Merial, Intervet-Schering plough or Virbac and has already been licensed to 4 companies for the production o...

Axial Biotech Names New VP of Reimbursement and Regulatory Affairs

...mic Health's Part B Medicare Carrier. Wolf has also worked at Esoterix (now LabCorp) as Vice President of Contracts, and has worked at both Schering plough and Searle Pharmaceuticals as a hospital and managed care specialty sales representative. She is a former President and board member of the California...

Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development

...omes to Emisphere with over 16 years of commercial experience in the pharmaceutical industry. In his most recent capacity at Organon, part of Schering plough Corporation, he was Leader of the Contraception Therapy Area and a member of the Corporate Executive Leadership Team. Also at Organon, he served as Se...

Veteran Drug Industry Executive to Become President of CTI

...er at Berlex Oncology. He was responsible for the U.S. oncology operations with sales of over $160 million. Prior to Berlex, Philips was with Schering plough in U.S., global, and international roles. He began his career with Bristol Myers, where he worked in a variety of therapy areas including oncology, ca...

Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year

...dications. REMICADE is a treatment for inflammatory diseases that Schering- plough markets in countries outside the United States (except in Japan and certain... statements, and there are no guarantees about the performance of Schering- plough stock or Schering-Plough's business. Schering-Plough does not assume the ob...

MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio

... Europe. Throughout her career she has served in regulatory affairs roles at Takeda Pharmaceuticals North America, Wellmark International and Schering plough Animal Health Corporation (formerly Mallinckrodt Veterinary, Inc.). Ms. Valenta earned a bachelor of science degree in biology from Colorado State Uni...

Innocoll Announces Closing of $30 Million Equity Financing Investment

...OL(R), GARACOLL(R), and CRONOCOL(R). In 2005, Innocoll acquired the worldwide marketing rights from Essex Chemis AG, an affiliated company of Schering plough Corporation (NYSE: SGP ) and in August 2007 sold its marketing rights, with the exception of the U.S., to EUSA Pharma. GENTAMICIN SURGICAL IMPLANT is...

Schering-Plough Completes Acquisition of Organon BioSciences

...nces acquisition, and the pipeline of the combined company. Forward-looking statements relate to expectations or forecasts of future events. Schering- plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering- Pl...

Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.

...pany's plans and future actions and the expected timelines. Forward-looking statements relate to expectations or forecasts of future events. Schering- plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering- Pl...

Nitec Pharma Expands Senior Management Team

...ndustry. Most of his career was spent with Key Pharmaceuticals and Schering plough (SP) where he was involved in US sales and marketing, managed care, global ...obal Marketing Cardiovascular Business Unit, and then moved to the Schering plough Research Institute, where he was responsible for developing and implementin...